Centella Asiatica in Skincare: Why Extract Quality and Formula Context Matter

Centella asiatica has moved from traditional botanical use into serums, creams, masks, and products marketed for stressed-looking skin. Many shoppers know it by the shorter name “cica,” which can make the category feel simple: find cica on the label and expect a calming product. Formulators see a more complicated picture.

Centella can enter a formula as a leaf extract, whole-plant extract, water, cell-culture material, standardized triterpene blend, isolated madecassoside, or another supplier-specific preparation. Those materials do not necessarily contain the same constituents, behave the same way, or carry the same evidence. The value of a Centella product therefore depends on the exact raw material, the complete formula, appropriate testing, and claim language that reflects what has actually been supported.

“Cica” Is a Marketing Name, Not a Material Specification

The common names cica and gotu kola can help consumers recognize the plant story, but a product-development team needs the botanical identity and INCI name. Plant part, extraction solvent, extract ratio, carrier, preservation system, solids content, and standardization can all affect composition. A water-based leaf extract is not equivalent to purified madecassoside, and neither is automatically equivalent to a standardized blend of triterpenes.

Even two materials with similar ingredient declarations may differ in color, odor, sediment, solubility, or concentration. One supplier may deliver an extract in water and glycerin; another may provide a dry powder. These differences influence addition order, target use level, preservation, pH, aesthetics, cost, and what will appear on the finished ingredient list.

Know the Major Triterpene Names

Centella research frequently discusses asiaticoside, madecassoside, asiatic acid, and madecassic acid. They are related triterpenoid constituents, but mentioning one in a paper does not prove that every commercial Centella extract contains a meaningful or comparable amount. If a brand wants a constituent-led story, it should request the supplier’s specification and analytical method rather than infer composition from the plant name.

A standardized extract can make development more reproducible when the supplier defines a marker range and tests each lot against it. Standardization still does not turn ingredient-level data into automatic finished-product performance. It simply provides a clearer starting material and a better basis for quality control.

What the Current Evidence Supports

Centella and its triterpenes have been studied in laboratory, animal, delivery-system, and human contexts. Much of the literature focuses on wound healing or dermatological conditions. That research may help scientists understand mechanisms, but a cosmetic founder should not translate therapeutic endpoints directly into claims for an over-the-counter beauty serum.

A June 2026 study compared a standardized Centella extract formulated with phospholipids against an unformulated dry extract in human dermal fibroblast models. The formulated material showed stronger effects in several laboratory measurements related to oxidative stress, inflammatory stimuli, and collagen homeostasis. The authors described the findings as preliminary and called for confirmation in more physiologically relevant models. That is emerging formulation research—not proof that any cica cream will produce the same visible outcome in consumers.

An August 2026 study designed a madecassoside microemulsion and measured delivery, skin retention, irritation response, and short-term physical stability. It demonstrated that the vehicle materially changed delivery in experimental models. It did not establish a universal benefit for the word “microemulsion,” nor did it validate every formula containing madecassoside.

The useful lesson is broader than either study: the preparation and vehicle can change the behavior of a botanical constituent. Founders should separate four evidence levels—traditional use, preclinical mechanism, ingredient-specific testing, and finished-product consumer or clinical testing—rather than blending them into one claim.

Extract Quality Changes the Development Conversation

Botanical sourcing requires more than a marketing origin story. A manufacturer may review the supplier, botanical species, plant part, extraction process, carrier composition, identity testing, microbiological limits, heavy-metal or pesticide information where relevant, allergen statements, storage conditions, retest date, and certificate of analysis. The appropriate documentation depends on the material and intended market.

Color and odor also matter. A concentrated botanical extract may darken a pale formula or contribute an earthy scent. Trying to hide those characteristics can require color adjustment, fragrance decisions, a different use level, or opaque packaging. Natural variation should be understood and controlled within an acceptable specification; it should not be discovered after printed packaging and campaign photography are complete.

Safety Is Finished-Formula Work

The Cosmetic Ingredient Review assessed nine Centella-derived cosmetic ingredients and concluded they were safe in the described practices of use and concentration when formulated to be non-sensitizing. That qualification matters. Ingredient safety information supports development, but the responsible company still needs safety substantiation for the marketed product under its intended conditions of use.

A leave-on facial serum, an eye-area product, and a rinse-off mask create different exposure and consumer-use questions. The complete formula—including fragrance, preservation, supporting actives, packaging, and directions—should guide the safety and testing plan.

Formulation Determines the Customer Experience

A Centella ingredient does not create a soothing-feeling product by itself. The base must deliver the intended texture, spread, absorption, finish, and compatibility with the rest of the routine. Humectants can support immediate hydration; emollients and conditioning agents can improve softness; rheology modifiers shape cushion and slip. These formula-level effects may be more noticeable to the customer than the botanical story.

Solubility and Delivery Are Material-Specific

A water-soluble extract may fit easily into a gel serum but still introduce electrolytes that affect viscosity. A dry standardized extract may require controlled dispersion. Lipid-associated systems can change processing and emulsion design. Isolated madecassoside is relatively hydrophilic and large, which is one reason researchers continue to investigate delivery systems. A founder should ask what the delivery approach is intended to improve—incorporation, stability, deposition, release, or penetration—and what data support that purpose.

“Advanced delivery” is a marketing claim unless it is connected to a defined technology and relevant evidence. Encapsulation or a microemulsion may add value, but the system must remain stable in the final formula and through manufacturing, packaging, storage, and use.

Processing, Preservation, and Packaging

Supplier instructions may specify temperature, pH, mixing, or cool-down addition. A botanical liquid can bring water and nutrients into the system, while a multi-component extract may interact with preservatives or chelators. Preservation should be evaluated in the complete formula rather than assumed from the raw material.

Packaging should protect the product and make dosing practical. An airless pump may reduce repeated consumer contact; an opaque package can help manage a naturally colored formula and control light exposure; a jar may support a rich cream but creates different contamination and usage conditions. Compatibility testing should include the chosen formula, closure, decoration, and expected storage orientation.

Claims Should Describe Cosmetic Outcomes

Centella marketing often borrows words such as heals, repairs wounds, treats inflammation, or reverses damage from medical and preclinical literature. Those statements can imply therapeutic or structure-function effects. A cosmetic sold in the United States should use truthful, substantiated language focused on appearance, cleansing, beautifying, or conditioning.

Depending on the evidence, a finished product might be positioned to help skin feel comfortable, support a hydrated appearance, visibly reduce the look of temporary redness, or leave skin looking smoother. The exact wording should reflect the substantiation available for that formula. “Cica-inspired,” “with Centella extract,” and “madecassoside serum” are ingredient stories; they do not independently substantiate an outcome.

The product name, package, website, ads, retailer copy, testimonials, and creator scripts should remain within the same claim territory. A careful label can still be undermined by a social caption that promises treatment.

Centella in Private-Label and Custom Skincare Development

A private-label cica product can make sense when a stable base, suitable package, and supporting documentation already exist. The founder can focus on audience, routine placement, sensory fit, branding, and a defensible claim set while reducing development complexity.

Custom formulation is useful when the brand requires a particular standardized extract, constituent, delivery technology, texture, fragrance position, or combination of supporting ingredients. That path also requires more sourcing, compatibility work, prototype evaluation, testing, and scale-up planning.

Choose the route based on what must be distinctive. If the brand’s advantage is education, service, packaging, or regimen design, a strong private-label formula may be sufficient. If extract identity and delivery are central to the product promise, custom development can provide the control needed to build that story responsibly.

What Skincare Brand Founders Should Consider

Before approving a Centella concept, ask for answers that connect the marketing name to a controlled finished product:

What is the exact INCI name, plant part, extract form, carrier, and supplier-recommended use level?
Is the material standardized to named triterpenes, and how is that specification verified?
Which evidence applies to the exact material, and which findings are only preliminary or preclinical?
How will the extract affect color, odor, pH, viscosity, preservation, and package choice?
What safety, stability, compatibility, microbiological, and consumer testing will support the finished product?
Which cosmetic claims can be used consistently across every sales and marketing channel?

Finally, define why the product deserves a place in the line. “Cica” can attract attention, but reorders depend on a recognizable use case, pleasing texture, convenient package, realistic directions, and an experience that fits the customer’s routine.

Build a Specific Centella Product, Not a Generic Cica Story

Centella asiatica offers a credible botanical platform, but the name alone cannot carry a formula. Extract identity, constituent profile, delivery, processing, preservation, packaging, safety, and finished-product evidence determine what the brand can responsibly say and what the customer will experience.

Derma Essentials Lab can help founders evaluate botanical materials, compare private-label and custom options, refine texture and supporting ingredients, select packaging, and plan testing and scalable U.S. manufacturing. Start with the intended user and product role, then choose the Centella material that can support that plan—not the other way around.